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Abstract
Monkeypox virus (MPV) is a zoonotic Orthopoxvirus and a potential biothreat agent that causes human disease
with varying morbidity and mortality. Members of the Orthopoxvirus genus have been shown to suppress antiviral
cell defenses, exploit host cell machinery, and delay infection-induced cell death. However, a comprehensive study
of all host genes and virus-targeted host networks during infection is lacking. To better understand viral strategies
adopted in manipulating routine host biology on global scale, we investigated the effect of MPV infection on
Macaca mulatta kidney epithelial cells (MK2) using GeneChip rhesus macaque genome microarrays. Functional ana-
lysis of genes differentially expressed at 3 and 7 hours post infection showed distinctive regulation of canonical
pathways and networks. While the majority of modulated histone-encoding genes exhibited sharp copy number
increases, many of its transcription regulators were substantially suppressed; suggesting involvement of unknown
viral factors in host histone expression. In agreement with known viral dependence on actin in motility, egress, and
infection of adjacent cells, our results showed extensive regulation of genes usually involved in controlling actin
expression dynamics. Similarly, a substantial ratio of genes contributing to cell cycle checkpoints exhibited con-
certed regulation that favors cell cycle progression in G1, S, G2 phases, but arrest cells in G2 phase and inhibits
entry into mitosis. Moreover, the data showed that large number of infection-regulated genes is involved in mole-
cular mechanisms characteristic of cancer canonical pathways. Interestingly, ten ion channels and transporters
showed progressive suppression during the course of infection. Although the outcome of this unusual channel
expression on cell osmotic homeostasis remains unknown, instability of cell osmotic balance and membrane
potential has been implicated in intracellular pathogens egress. Our results highlight the role of histones, actin, cell
cycle regulators, and ion channels in MPV infection, and propose these host functions as attractive research focal
points in identifying novel drug intervention sites.
Introduction
Monkeypox virus is a double-stranded DNA virus and
one of the human pathogenic orthopoxviruses that
include Variola (VARV), cowpox (CPX), and Vaccinia
(VACV) viruses. The virus causes a disease that mani-
fests similarly to smallpox, but with milder morbidity
and lower mortality rates [1]. Variation in MPV viru-
lence has been observed and mapped to defined geo-
graphic origins, e.g., virus isolates from Central Africa
are more virulent than those from Western Africa
[2,3]
Recent advances in molecular biology and genomics
have improved our understanding of viral infection
and replication mechanisms. Monkeypox virus has a
relatively large genome of about 196,858 base pairs,
encoding 190 open reading frames, which constitute
the bulk of the material needed for viral replication in
cell cytoplasm [4]. Viral entry into cells is dependent
on cell type and viral strain, and occur after an initial
attachment to cell surface through interactions
between multiple viral ligands and cell surface recep-
tors [5] such as chondroitin sulfate [6] or heparan sul-
fate [7,8]. Subsequent crossing of cell membrane is
mediated by a viral fusion event with cell membrane
under neutral pH conditions [9], or by endosomal
uptake via a macropinocytosis-like mechanism that
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[12]. Once in the cell cytoplasm, the virus releases pre-
packaged viral proteins and enzymatic factors that dis-
able cell defenses and stimulate expression of early
genes [13-15]. Synthesis of early proteins promotes
further uncoating, DNA replication, and production of
intermediate transcription factors. In following stage,
intermediate genes are transcribed and translated to
induce the expression of late genes that function
mainly as structural proteins, enzymes, and early tran-
scription factors. Eventually, membrane structures will
appear and unit virion genomes processed from DNA
concatemers are assembled into nascent virions that
contain all enzymes, factors, and genetic information
needed for a new infectious cycle.
The detailed available information about viral gene
functions and its programmed expression during infec-
tion exceeds current knowledge of corresponding events
in the host. Furthermore, although poxviruses are con-
sidered one of the most self-sufficient viral families, they
remain unable to reproduce in extracellular environment
and known to have limited host range, which suggest
dependence on host elements [16,17]. Therefore, identi-
fication of these specific host elements and pathways
that are essential for viral replication will enrich our
knowledge of host response to viral infection, and may
prove valuable in identifying potential targets for anti-
viral therapies.
Microarrays have been used in genome exploration
and profiling with special focus on understanding
dynamics of viral gene expression and pathogenesis
[18,19]. However, a paucity of work employed this tool
in examining host response to infections with poxviruses
generally [20-22], and more specifically in the case of
MPV. Because combining microarray technology with
modern data mining tools allows further information
extraction at genome-wide levels, we used whole gen-
ome rhesus macaque microarrays in combination with
Ingenuity Pathways Analysis (Ingenuity® Systems, http://
www.ingenuity.com) to investigate the effect of MPV
infection on host Maccaca mulata kidney epithelial cells
transcriptome, and address gaps in host response during
MPV infection. Functional and canonical pathway analy-
sis of differentially expressed genes at 3 and 7 hours
post-infection (hpi) time points validated many of the
known host gene responses to poxvirus infection and
introduced new sets of interesting functions and path-
ways in areas of cell death and apoptosis, actin
dynamics, ion channels and transport, and cell cycle reg-
ulation. Our data points to a vital role for these cell
functions in MPV infection, and hence, signify their
value in poxviruses’ infection diagnosis and treatment
studies.
Materials and methods
Cell culture and viral infection
Monkeypox virus-Katako Kombe strain (MPV-KK) was
propagated in Vero E6 cells maintained in Eagle’sM i n i -
mum Essential Medium with non-essential amino acids
(EMEM/NEAA) supplemented with 2 mM L-glutamine,
10% heat-inactivated fetal bovine serum (FBS), 10 mg/L
Gentamycin, 250 μg/L Fungizone, and buffered at pH
7.4 with 10 mM HEPES [23]. Viral titers were deter-
mined by the plaque assay [24]. As described previously
[25], monolayer of Vero E6 were inoculated with serial
dilutions of viral suspension and allowed to adsorb for
30 min at room temperature. The viral inoculate was
removed and cells were washed twice with PBS then
incubated with culture medium for 5 days. To count
plaques, culture medium was removed and cells were
fixed and stained simultaneously using 30% formalin, 5%
ethanol (vol/vol) solution containing 1.3 g/L crystal
violet.
For time points and control samples, MK2 cells were
grown in the same culture medium described above but
in absence of antibiotics and Fungizon for at least
2 days before infection with MPV. Culture medium was
removed and cells were inoculated with crude monkey-
pox virus-Katako Kombe strain (MPV-KK) at MOI of 3.
Virus was adsorbed for 30 min at 37°C with gentle rock-
ing for 15 sec each 10 min, then cells were washed twice
with room temperature equilibrated PBS, fresh culture
medium was added, and cells were incubated for 3 or 7
hours. Control cells were handled identically except for
exposure to virus.
RNA and cDNA preparation, labeling, hybridization, and
scanning
RNA was extracted using TRIzol LS (Invitrogen) accord-
ing to the manufacturer’s recommended protocol.
Briefly, 200 μl of chloroform (Sigma Aldrich, St. Louis,
MI) was added to 5×10
6 infected and non-infected con-
trol cells harvested in 1 ml of TRIzol LS reagent (Invi-
trogen). Solutions were mixed thoroughly and incubated
for 10-15 min at 4°C, then centrifuged for 20 min at
14,000 rpm in 4°C. After centrifugation, the aqueous
phase was removed, added to an equal volume of 2-pro-
panol (Sigma-Aldrich). After overnight incubation at
-20°C, the mixture was centrifuged for 20 min at 14,000
rpm in 4°C. Supernatant was removed and the RNA pel-
let was washed with 80% ethanol (Sigma Aldrich), dried,
and dissolved in 100 μl of RNase-free water (Ambion,
Austin, TX). Possibly present contaminating DNA was
eliminated using Turbo DNA-free kit (Ambion), and
RNA clean up was performed using RNeasy kit (Qiagen,
Valencia, CA). Quality and quantity of RNA was evalu-
ated using Experion automated electrophoresis station
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cules, CA). Clean sharp peaks representing intact rRNA
were confirmed for each preparation by two indepen-
dent workers.
cDNA was synthesized using One-cycle cDNA
Synthesis kit (Affymetrix, Santa Clara, CA) in presence
of poly-A RNA controls. Double-stranded cDNA sam-
ples were cleaned up and biotin labeling of antisense
cRNA was carried out with the IVT Labeling Kit
(Affymetrix, P/N 901229). Material was cleaned up
then fragmented before hybridization overnight.
Microarrays (Affymetrix, P/N 900656) were scanned
using the Affymetrix GeneChip scanner following
standard Affymetrix protocols [26] after carrying out
all washing and staining steps as recommended by the
manufacturer.
Microarray validation by RT PCR
RT PCR was performed utilizing the Superarray human
common cytokines panel (PAHS-021E-4, Superarray,
Frederick MD, 21703). Reactions were performed
according to manufacturer’s guidelines for both time
points in 10 μl volumes using the 384 plate format that
allow gene expression analysis in quadruplicate. Results
showed a strong correlation of gene expression levels
with that obtained using microarray.
Data analysis
The Affymetrix CEL files were imported into Gene-
Spring GX software v 7.3.1 (Agilent), which allows
multi-filter comparisons using data from different
experiments, to perform the normalization, generation
of restriction lists and functional classifications of the
differentially expressed genes.
Normalization was applied in two steps: i) “per chip
normalization” by which each measurement was divided
by the 50th percentile of all measurements in its array;
and ii) “per gene normalization” by which each treated
sample was normalized against its respective control
(mock-treated) sample.
The expression of each gene was reported as the ratio
of the value obtained relative to the control condition
after normalization of the data. Transcripts whose levels
reproducibly changed were identified using one-way
parametric analysis of variance with a P-value cutoff of
0.05 (false discovery rate of 5%). The changes in tran-
script levels are expressed as the fold change in signal
between control and treated samples.
Two-dimensional clustering was carried out based on
samples and genes for visualization and assessment of
reproducibility in the profile of the significant genes
across biological replicates.
Results
Dataset overview
To characterize and measure changes in transcriptome
of cells infected with MPV, we infected 10
7 Macaca
mulatta kidney epithelial cells (MK2) and incubated
them for 3 or 7 hpi. Cells were infected at high multipli-
city to enhance infection probability and improve signal
to noise ratio. Infected cells were washed after virus
adsorption to reduce response to any biological factors
in the seed, and to avoid an infection continuum that
may desynchronize virus replication stages. We selected
the two time points not to exceed 7 hpi to avoid possi-
ble entry into a second cycle of viral replication, and to
minimize artifacts that might arise from cell lysis after
viral maturation and release of intracellular components
[18]. We mock-infected a similar number of cells and
used them as controls for each time point. The experi-
ment was done in triplicate, and 47,000 rhesus macaque
transcripts potentially present in purified RNA from
each sample were interrogated by 52,000 probe sets/
microarray.
We employed RT-PCR as a tool to validate microar-
ray results. Expression levels of nine genes encoding
eight cytokines and one housekeeping protein were
assessed and the resulting fold change for each gene
was compared with corresponding calculated measure-
ments from the microarray study. The RT-PCR mea-
surements were carried out in quadruplicate, and cycle
threshold (Ct) values in each observation were normal-
ized to the average of five housekeeping genes and to
the expression level of the same gene in control mock-
infected cells as described in microarray experiments.
Despite consistent mild lower fold change values in all
assessed genes by RT-PCR, a direct correlation was
evident between the results obtained in both techni-
ques, and 15 out of the 18 gene expression measure-
ments in 3 hpi (Fig. 1A) and 7 hpi (Fig. 1B) were
concordant. The moderately staggered prediction in
gene regulation in the other three measurements coin-
cided with large Ct values, which were near or beyond
RT-PCR detection sensitivity limitations. Likewise, the
observed lower and consistent fold change FC esti-
mates from RT-PCR where mainly due to different
normalization methods used for each approach. The
strong correlation in results of RT-PCR and microarray
was mutually validating and instigated subsequent data
analysis.
MPV compromises host’s biological activities with a
dominating global downregulation
Downregulation was reported as the hallmark of gene
expression modulation in Vaccinia-infected human
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cynomolgus macaques (Macaca fascicularis)[ 2 1 ] .I n
this study, we identified 2,702 transcripts that exhib-
ited statistically significant changes in copy numbers
with P values < 0.05. This represents about 5.7% of the
total interrogated host transcripts on the microarray
(Fig. 2A). In agreement with previously reported
results [21,22], the majority of transcription changes
we observed were downregulation. More than 89% of
the regulated genes or 2,407 genes exhibited steady
downregulation in both 3 and 7 hpi time points, while
only 295 genes or 10.92% of total regulated gene
showed upregulation under the same statistical con-
straints (Fig. 2B).
Up- and down-regulated genes exhibit varied temporal
regulation distribution
Because MPV exhibit well-defined temporal gene
expression stages that were classified into early, inter-
mediate, and late stages, we anticipated the host
response to exhibit some sort of an analogous pattern.
This may be represented in variable temporal expression
of regulated host genes, where a subset will exhibit a
higher copy number at early time point followed by a
d e c l i n ea tl a t et i m ep o i n ta st h ei n d u c i n gv i r a lp r o t e i n
or gene decreases or disappears. We followed peaks of
gene expression regulation for each of the differentially
expressed genes across both time points by dividing
gene expression fold change (FC) at late time point (7
hpi) by FC of the same gene in early time point (3 hpi).
Calculated fold change ratios (FCRs) 7/3 hpi for all
2,407 down-regulated genes are plotted in (Fig. 3A).
Bars represent the average FCR for each consecutive
100 genes after sorting them according to their FCR
values from smallest to highest for data clarity. A plot
for all 295 upregulated genes was made following identi-
cal steps (Fig. 3B), but bars represent the average FCR of
10 sequential genes. Genes with FCR > 1 indicate a rela-
tively greater regulation in later stages, while < 1 ratio
points to greater regulation in early stage. Only 7.9% of
the downregulated genes showed higher fold change
early in the course of infection (Fig. 3A), while 51.1% of
the upregulated genes exhibited similar temporal expres-
sion trend (Fig. 3B). In contrast with downregulated
genes (Fig. 3A), peaks of host gene upregulation were
almost equally distributed across infection time points
(Fig. 3B). This important difference in the distribution
of temporal up and downregulated genes is a new land-
mark of global host gene regulation by poxviruses sec-
ond to known dominant host genes downregulation
[20-22]. While the steady increase in host gene suppres-
sion denotes known continuous viral stifling of host
functions such as innate immune response and antiviral
cell defense mechanisms, the variation in host gene
upregulation intensity seems to mark the stage depen-
dent viral gene expression and need for specific host
material or machinery.
Functional gene clusters
We used Ingenuity pathway analysis (IPA) to identify
the main host functions and canonical pathways influ-
enced by viral infection. The differentially expressed
genes at 3, 7 hpi time points fell into diverse functional
categories including enzymes, transcription regulators,
kinases, phosphotases, peptidases, transmembrane recep-
tors and G protein coupled receptors, transporters,
translation regulators, and micro RNAs (Table. 1). To
reduce noise in functional analysis, we applied a second
Figure 1 Validation of microarray results by quantitative real-
time PCR. Copy number of eight common cytokines and a house
keeping gene (B2M) were calculated based on RT-PCR Ct values.
Fold change of genes expression is plotted on Y-axis after
normalization to mock-treated samples. Results plotted to compare
calculated fold change in expression of each gene at 3 hpi (A) or at
7 hpi (B) using Microarray (grey bars) and RT-PCR (black bars).
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Figure 2 (A) Gene expression overview of Macaca mulatta kidney epithelial cells infected with MPV. (A) Using one-way ANOVA, a total of
2702 elements exhibited reproducible change (P-value ≤ 0.05). This represented 5.7% of the total 47000 interrogated transcripts on the GenChip.
About 89% of the differentially expressed transcripts were suppressed and less than 11% were up-regulated. (B) Expression data for significantly
influenced transcripts were hierarchically clustered. Columns represent triplicate (A, B, C) of time points 3 and 7 hpi. Color intensity reflects fold
change relative to control (mock-transfected) cells. Red and green indicate up- and downregulation respectively.
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Figure 3 Up- and down-regulated transcripts follow different distribution patterns during infection progression.E a c hb a rr e p r e s e n t s
average fold-change ratios (FCRs) of gene expression at 7 hpi/3 hpi for either 100 consecutive downregulated genes (A), or 10 upregulated
genes (B), after sorting all genes according to their FCR values from smallest to largest. Genes with average FCR values < 1 are in grey and those
with values > 1 are in black. Results show most downregulated genes maintained an increasing suppression trend in the course of infection as
more than 92% of the genes gave fold-change ratio > 1 (A). The 295 upregulated genes exhibited more balanced distribution between 7 and 3
hpi with about 51% of the genes having higher fold change at early time point.
Alkhalil et al. Virology Journal 2010, 7:173
http://www.virologyj.com/content/7/1/173
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FC in addition to the t-test filter with P values < 0.05
already in place. A total of 1,013 and 1,720 genes from
3 and 7 hpi time points, respectively, met analysis
thresholds and were used in a comparative functional
analysis to identify unique and common influenced host
functions for both time points. Results were scored
based on Fisher’s exact test, and functions with P-values
≤ 0.05 were considered statistically significant. When
defined the -log (P-value) ≥1.301 as a significant differ-
ence in random genes clustering probability for a given
function between the two time points, functions clearly
separated into either time point dependent or indepen-
dent categories (Fig. 4). Functions relating to cell signal-
ing, cell cycle, cell death, transcriptional modification,
and DNA processing were more significant in 3 hpi
time point (Fig. 4A), and while protein synthesis and
molecular transport functions were indentified with sig-
nificant P-values only at 7 hpi, and RNA damage and
repair was found to be unique to 3 hpi time point (Fig.
4A). Time-point independent functions exhibited com-
parable -log (P-value) in both time points and included
metabolism of essential building blocks such as amino
acids, lipids, and carbohydrates (Fig. 4B), and other
functions related to cell morphology, cellular develop-
ment, small molecule biochemistry, and posttransla-
tional modification (Fig. 4B).
The expression of histones exhibited interesting pat-
tern with potentially important implications in viral
replication. Functional analysis showed steep upregula-
tion of histones in both time points with sharp increase
through the course of MPV infection. Except for
HIST3H2A, all other core histone genes including
HIST1H3I, HIST1H1D, HIST1H2BJ, HIST1H2AD, and
HIST4H4 exhibited upregulation (Table. 2). The linker
histone H1F0, was downregulated with an increasing
trend. Unlike the vast increase in histones expression,
genes encoding major transcription regulators of his-
tones expression such as CITED2, NCOA3, CREB1,
YY1, and HDAC2 showed increasing suppression
throughout infection. Similarly, many enzymes control-
ling major modifications of histones and chromatin
organization dynamics of the host, including FBXO11,
PRMT3, MYST2, MYCBP2, and RARS2 showed steady
downregulation (Table. 2).
Another set of genes encoding mainly transmembrane
proteins that function as ion channels or transporters
were progressively suppressed during MPV infection.
Out of 10 identified channels that exhibited statistically
significant downregulation in the both data sets, eight
w e r ed o w n r e g u l a t e da t1 . 8 - f o l dc h a n g eo rm o r e( T a b l e .
3). The majority of the identified channels were loca-
lized to the plasma membrane and only two had
unknown locations in the cell. Identified infection-regu-
lated channels covered the transport of the principal
ions Na
+,K
+,C l
-,a n dC a
++ which function in a con-
certed manner to define transmembrane potential and
maintain cellular osmotic balance.
Canonical pathways analysis
To identify the effect of viral infection on major biologi-
cal processes in the cell, we examined potential enrich-
ment of all differentially expressed genes in known
canonical pathways. The two data sets were analyzed
using IPA library of canonical pathways. Genes exhib-
ited ≥ 1.8 FC and associated with a canonical pathway
in the Ingenuity pathways knowledge database were
considered for the analysis. Both data sets contained
Table 1 Functional distribution of differentially expressed genes at 3, 7 hpi time points
Gene function category Number of genes Up regulated Down regulated FC < 1.8
3 hpi 7 hpi 3 hpi 7 hpi 3 hpi 7 hpi
transporter 122 10 8 43 88 69 26
transmembrane receptor 19 3 3 5 13 11 3
translation regulator 16 5 5 5 9 6 2
transcription regulator 261 12 12 107 197 142 52
phosphatase 48 2 1 17 33 29 14
peptidase 48 4 4 9 27 35 17
other 1278 128 104 452 852 697 322
microRNA 1 - - 1 1 0 0
ligand-dependent nuclear receptor 7 - - 1 4 6 3
kinase 134 8 4 58 96 68 34
ion channel 11 - - 5 9 6 2
growth factor 8 1 1 4 4 3 3
G-protein coupled receptor 13 1 2 8 10 3 3
enzyme 308 32 31 89 199 187 78
cytokine 5 2 2 1 1 2 2
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Figure 4 Comparative functional analysis of differentially expressed genes at 3 and 7 hpi. (A) Represents functions exhibiting -log (P-
values) differences ≥ 1.301 between 3 and 7 hpi time points. Few identified functions were unique to one time point only under adopted
statistical constraints. (B) Equally present functions in both time points showing a -log (P-value) differences ≤ 1.301. All functions were identified
with P-values ≤ 0.05 or -log (P-value) = 1.301 thresholds (dotted black lines).
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ties. The number of genes eligible for pathway analysis
was 680 and 1,134 genes for time point 3 and 7 hpi,
respectively. The significance of the association between
a subset of genes in data sets and the canonical pathway
was measured in two ways: 1) ratio of the number of
genes from the data set that mapped to the pathway
divided by the total number of genes that mapped to
the canonical pathway, and 2) Fischer’s exact test P-
value, which determines the probability of random
association between the genes in the datasets and the
canonical pathway.
Data set 3 h mapped into 185 pathways with 32 meet-
ing ratio of ≥ 10% and 70 meeting a threshold of
Pv a l u e≤ 0.05. Similar analysis of data set 7 h resulted
in genes mapping to 176 pathways with 72 achieving a
ratio ≥ 10% and 44 having P values ≤ 0.05. Common
canonical pathways in both time points include molecu-
lar mechanism of cancer, glioma signaling, hepatocyte
growth factor (HGF) signaling, cell cycle regulation by
Table 2 List of differentially expressed genes involved in histones dynamics in MPV- infected cells
Symbol Type Fold Change Entrez Gene Name
3h 7h
FBXO11 enzyme -1.98 -2.95 F-box protein 11
PRMT3 enzyme -1.81 -3.04 protein arginine methyltransferase 3
MYST2 enzyme -1.69 -3.73 MYST histone acetyltransferase 2
MYCBP2 enzyme -1.66 -2.01 MYC binding protein 2
RARS2 enzyme -1.41 -1.61 arginyl-tRNA synthetase 2, mitochondrial
CITED2
a transcription regulator -8.75 -309.73 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
NCOA3
a transcription regulator -2.29 -4.76 nuclear receptor coactivator 3
CREB1
a transcription regulator -1.91 -2.59 cAMP responsive element binding protein 1
YY1
a transcription regulator -1.58 -2.60 YY1 transcription factor
HDAC2 transcription regulator -1.38 -1.57 histone deacetylase 2
HIST3H2A histone -2.49 -9.19 histone cluster 3, H2a
H1F0 histone -2.45 -6.15 H1 histone family, member 0
HIST1H3I histone 2.64 22.09 histone cluster 1, H3i
HIST1H1D histone 7.49 42.62 histone cluster 1, H1d
HIST1H2BJ histone 16.57 160.56 histone cluster 1, H2bj
HIST1H2AD
a histone 46.04 994.02 histone cluster 1, H2ad,1
HIST4H4
a histone 1964.01 2989.9 histone cluster 4, H4
a Average gene expression values is presented for genes with multiple identifiers.
Table 3 List of MK2 cell genes exhibited differential expression upon infection with MPV and encoded ion channels or
related proteins
Symbol Type Location Fold Change Entrez Gene Name
3h 7h
CLCN3
a ion channel Plasma Membrane -2.02 -6.68 chloride channel 3
KCNMA1 ion channel Plasma Membrane -2.11 -3.94 potassium large conductance calcium-activated channel, subfamily M, alpha member 1
MST150 ion channel Unknown -2.00 -3.63 MSTP150
KCMF1 enzyme Unknown -1.77 -2.81 potassium channel modulatory
factor 1
SCNN1A ion channel Plasma Membrane -1.62 -2.68 sodium channel, nonvoltage-gated 1 alpha
CUL5 ion channel Cytoplasm,
Nucleus
-1.69 -2.51 cullin 5
KCTD20 ion channel Unknown -1.24 -1.92 potassium channel tetramerisation
domain containing 20
TRPC1 ion channel Plasma Membrane -1.87 -1.87 transient receptor potential cation
channel, subfamily C, member 1
CACNB3 ion channel Plasma Membrane -1.31 -1.83 calcium channel, voltage-dependent,
beta 3 subunit
SCLT1 transporter Plasma Membrane -1.62 -1.64 sodium channel and clathrin linker 1
TPCN1 ion channel Plasma Membrane -1.34 -1.60 two pore segment channel 1
a Average gene expression values are presented for genes with multiple identifiers.
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signaling, cell cycle: G2/M DNA damage checkpoint
regulation, cell cycle: G1/S checkpoint regulation, ataxia
telangiectasia mutated protein (ATM) signaling, ephrine
receptor signaling, and virus entry via endocytic path-
ways. Observed order variation of identified pathways in
examined time points when sorted by their gene ratios
or P values underscores the time dependent viral activity
(Fig. 5).
The following analysis focuses on most relevant path-
ways that were identified with strong statistical support
of P-values < 0.05 and ratio > 10% in either time point.
Molecular mechanisms of cancer (MMC)
With 370 molecules localized to cell membrane, mito-
chondrion inner and outer membrane, cell cytoplasm,
and cell nucleus, this pathway is considered one of the
most complex known pathways. Forty-eight genes of
data set 7 hpi clustered to MMC to cover 13% of total
pathway molecules with P-value of 1.25e-5, making it
the first pathway influenced by MPV infection. The 3
hpi data set showed lower gene ratio of 9.5% but with a
tighter correlation at lower P-value of 2.82e-6 (Fig. 6).
MMC pathway can be triggered by diverse stimuli
including hormones, growth factors, cytokines, and
oncogenes. Each of these stimuli is capable of inducing
a variety of biological processes relating to cancer,
including cell cycle regulation and cell cycle check-
points, which were recognized in our analysis as inde-
pendent pathways, and therefore will be discussed
separately. The majority of the genes specific to cancer
mechanisms pathway are involved in apoptosis regula-
tion. Identified modulation in expression patterns of
these genes suggest signaling apoptosis in infected cells,
e.g., Noxa or PMAIP1 (phorbol-12-myristate-13-acetate-
induced protein 1) shows more than 44-fold upregula-
tion at 7 h PI. This molecule inactivates the anti-apop-
totic molecule Bcl2 (B-cell CLL/lymphoma 2)[27-29],
which regulates mitochondrial membrane potential by
controlling the voltage dependant anion channel
(VDAC) [30-32], consequently increasing the mitochon-
drial membrane permeability and the release of
cytchrome C that serves as a major apoptosis inducer
[33]. In addition to Bcl2 inactivation, the expression of
Bcl2 gene itself exhibited a significant -2.83-fold sup-
pression, which would enhance apoptosis signaling.
Apoptosis-induced cysteine-aspartic acid peptidases
(caspases) such as caspase 3, which enhance the degra-
dation of Bcl2 [30] and trigger subprograms for cell dis-
mantling and removal, exhibited 3.2-fold upregulation.
Caspase 7, 8, and 10 expression remained unchanged,
and only caspase 6 [34], which functions as a down-
stream enzyme in the caspase activation cascade,
showed mild -1.2 and -1.62 FC at 3, 7 hpi time points,
respectively. Other pro-apoptotic genes like BBC3 (BcL2
binding component 3) or PUMA [35] and p21 protein
(Cdc42/Rac)-activated kinase 2 or PAK2 [36] showed
similar suppression trend of -1.85 and -1.99 FC at 7 hpi,
respectively.
Proteosomal degradation has been associated with
apoptosis. Our results show a 4.05 FC upregulation of
nuclear factor of kappa light polypeptide gene enhancer
in B-cells inhibitor, epsilon NFKBIE, which mediates
cytoplasmic sequestering of transcription factor and acts
as a transcription repressor. The effect of NFKBIE upre-
gulation on apoptosis is unclear because it was reported
to exhibit a cell line dependence [37].
Cell division cycle 25 homolog A, B, and C expression
showed a remarkable regulation; e.g., Cdc25, which
plays a key role in promoting progress through S phase
[38], showed 1.7 FC, while Cdc 25 B and C, which regu-
late and promote entry into mitosis [39,40], exhibited
-4.3 and -1.92 FC, respectively. Similarly, cyclin -depen-
dent kinase regulators, cyclin E2 and cyclin D1, which
are strongly tied to a variety of cancers [41-43], showed
upregulation of 3.2 and 2.2 FC, respectively.
Other cell cycle regulators that have overlapping func-
tions with apoptosis mechanisms showed sharp downre-
gulation. This include members of the p21 RAS group
such as KRAS (v-Ki-ras2 Kirsten rat sarcoma viral onco-
gene homolog) and Ras homolog or the RHO GTPase
protein group including RHOB, RHOQ, RHOT1, and
RND3 (Fig. 6).
Ephrine signaling pathway (ESP)
The largest group of receptor tyrosine kinases (RTKs),
Eph receptor family and their ligands, Ephrines, were
identified among the main pathways that were influ-
enced by MPV infection. Genes in the 7 hpi data set
were enriched to ESP at ratio of 13.8% of the total 195
pathway genes with a P-value of 1.37e-4 (Fig. 5). The
percentage of pathway genes regulated by infection was
lower during the 3 hpi time point, reaching only a ratio
of 10.3% with P-value of 5.95e-5, and ranking fourth
among influenced pathways by MPV infection. Trans-
membrane receptors Eph A class, which contains eight
members of ephrine receptors and represent one of two
classes forming the entire receptors family [44], exhib-
ited significant suppression associated with downregula-
tion of key kinases and protein groups implicated in cell
morphology, cell proliferation, and cell repulsion. Of
these molecules, we mention FYN oncogene, RAS p21
protein activator (GTPase activating protein RAS-GAP)
1, p21 protein (Cdc42/Rac)-activated kinase (PAK), and
Rho-associated, coiled-coil containing protein kinase 1
(member of ROCK group) (Fig. 7). Interestingly, the
other class of ephrines family, Eph B, didn’ts h o wa n y
significant change in its expression in both time points.
However many molecules downstream of Eph B in the
signal cascade were downregulated, including intersectin
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Page 10 of 19Figure 5 Major influenced canonical pathways of MPV-infected MK2 cells. Relevant pathways are shown at 3 (A) and 7 (B) hpi. The primary
Y-axis shows the -log (P-value) of the probability for genes in data set to associate with identified pathway by chance. A threshold P-value of
0.05 or a -log (P) = 1.3 is presented in dotted line. The ratio of the number of genes from the data set that map to given pathway divided by
the total number of genes that map to the canonical pathway is shown in solid line. All enlisted pathways met ratios ≥ 0.1 in at least one of the
two time points (secondary Y-axis).
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Page 11 of 191 (SH3 domain protein), c-abl oncogene 1-RTK (ABL),
and Wiskott-Aldrich syndrome-like (WASL), cofilin 2
(CFL2), actin-related protein 2 homolog (ARP2), and
mitogen-activated protein kinase 4 (NcK) (Fig. 7).
Two proteins were up-regulated in this pathway,
ARPC5L (actin-related protein 2/3 complex, subunit 5-
like), which functions as an actin-binding protein and is
involved in regulation of actin filament polymerization
[45] and GNAS complex locus, which is a member of
G-protein alpha subunit that has an indirect effect on
signaling of ephrine pathway. The importance of this
pathway is due to its involvement in the modulation of
integrin activity, actin reorganization, and cellular
dynamics, which are all central to viral motility, exit and
invasion of proximal cells.
Ataxia telangiectasia mutated protein signaling pathway
Ataxia telangiectasia mutated protein (ATM) is a cell
kinase that phosphorylates a wide range of substrates in
many pathways regulating cell cycle, DNA repair, apop-
tosis, and cell survival. Data sets analysis showed mild
ATM downregulation of 1.3 and 1.5 FC in time points 3
and 7 hpi, respectively. Nonetheless, ATM pathway was
recognized in our analysis as one of the major pathways
influenced by MPV infection. Out of the 52 genes com-
prised in the ATM pathway, eight genes exhibited sig-
nificant expression modulation with P-value of 1.87e-3
at 3 hpi. The number of genes regulated at 7 hpi
increased to 10 genes, resembling 19.2% of the total
pathway components with P-value of 4.53e-3. The
observed suppression of ATM results in weaker
Figure 6 Heat-map of differentially expressed genes in MPV
infected MK2 cells that mapped to molecular mechanisms of
cancer pathway. Columns represent expression at 3 and 7 hpi in a
triplicate (A, B, C). Each row represents one gene that met analysis
cutoff of average fold change ≥1.8 in at least one of the two time
points and P-value ≤ 0.05 in both. A gradient of green and red
colors represent low and high relative fold change of gene
expression to mock- infected cells. Chance for random association
of listed genes at 3 or 7 hpi in this pathway is 2.82e-6 or 1.25e-5,
respectively.
Figure 7 Cluster Analysis of expression profile for genes of
ephrin receptor signaling pathway influenced by MPV
infection. Columns of the heat-map represent expression of genes
transcripts at 3 and 7 hpi in a triplicate (A, B, C). Each row
represents one gene that met the analysis parameters of ≥1.8
average fold change cutoff in at least one of the two time points
and P-value ≤ 0.05 in both. Gradient green and red color represents
low and high relative expression fold change to mock infected cells,
respectively. Chance for random association of listed genes at 3 or 7
hpi with this pathway is 5.95e-5 or 1.37e-4, respectively.
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response to DNA damage and routine DNA repair,
additionally, it disables a major apoptosis activation pro-
cess. The MPV infection influence on the pathway is
exacerbated further by the downregulation of many vital
ATM substrates needed for proper ATM signaling. This
includes activating transcription factor 2 (ATF2), c-abl
oncogene 1 receptor tyrosine kinase (c-Abl), and breast
cancer 1 (BRCA1) (Fig. 8).
Pathways involved in cell cycle regulation
A significant proportion of the genes in data sets 3 and
7 hpi were enriched in three major cell cycle regulation
pathways. Out of the 36 molecules found in cell-cycle
regulation by BTG family pathway, seven molecules
were found in each of the 3 and 7 hpi data sets with
P-values of 8.15e-4 at 3 hpi and 1.48e-2 at 7 hpi indicat-
ing the involvement of this pathway in early time point.
Essential genes to pathway signaling and G1 arrest were
severely suppressed (Figure. 9A). Retinoblastoma 1 (Rb)
and B-cell translocation gene-1 (BTG1) were downregu-
lated in both time points and reached -9.26 and -15.86
FC by 7 hpi. Furthermore, cyclin D1 and cyclin E exhib-
ited 4.18- and 2.77-fold increase at 3 hpi respectively,
and remained upregulated to similar levels at 7 hpi time
point. The products of these two genes function as reg-
ulators that inactivate the growth suppression activity of
Rb indirectly by promoting CDK kinases [46-48].
Phosphorylation of Rb by CDK kinase inactivates its
function, leading to the release of E2F and cell cycle
progression [49,50]. The net outcome of this pattern of
gene expression in this pathway is cell cycle release
from potential arrest in G1 phase and block of BTG1-
induced apoptosis.
The second pathway contributing to cell cycle regula-
tion that was influenced by infection is the cell cycle
G1/S checkpoint. The pathway consists of 59 molecules
from which eight molecules or 13.6% showed significant
regulation in both data sets (Fig. 9B). The calculated P-
values for random implication of this pathway were
2.71e-3 and 5.02e-2 for the 3 and 7 hpi, respectively.
Similar to regulation by the BTG protein family path-
way, phosphorylation of retinoblastoma Rb by CDK2
and CDK4/6 induces the release of transcription factor
E2F from an inhibitory complex, which in turn pro-
motes the transcription of necessary molecules for G1/S
phase progression [50-52]. Cell-division-cycle 25 homo-
log A (Cdc25A), which activates CDK2 and CDK4/6
[53-55], showed strong upregulation suggesting
enhancement of kinase activity that promotes G1/S
phase progression. Transforming growth factor b
(TGFb) that stimulates G1/S check point exhibited
almost steady suppression of -1.48 and -1.52 FC in both
time points [56,57]. Another mechanism of G1/S check-
point control is degradation of cyclin D and E after
Figure 8 Cluster analysis of expression profile for genes of ataxia telangiectasia mutated (ATM) pathway. Columns of the heat-map
represent expression of genes transcripts at 3 and 7 hpi time points in a triplicate (A, B, C). Each row represents one gene that met the analysis
criteria of ≥1.8 average fold change cutoff in at least one of the two time points and P-value ≤ 0.05 in both. Gradient green and red color
represents low and high relative expression fold change to mock infected cells, respectively. Chance for random association of listed genes at 3
or 7 hpi with this pathway is 1.87e-3 or 4.53e-3, respectively.
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Both time points show upregulation of cyclin D and E
expression with no change in GSKb expression despite
mild reduction in TGFb. This multigene expression pat-
tern in both data sets points to destabilized G1/M con-
trol checkpoint and enhancement of cell cycle
progression through this phase, especially in the early
time point as suggested by lower P-value and greater
gene regulation.
The third cell-cycle-related pathway identified in our
analysis was the G2/M DNA damage checkpoint
regulation pathway. About 14% of the total 43 molecules
comprised in this pathway exhibited significant expres-
sion modulation upon infection at time point 3 hpi with
P-value of 5.02e-2. Time point 7 hpi showed regulation
of 20.9% of total pathway with P-value of 1.19e-3, imply-
ing a wider pathway role during later stage of infection.
Progression of cell cycle into mitosis requires the activa-
tion of cell-division cycle-2 (Cdc2) by the rapid depho-
sphorylation of its tyrosine 15 (Tyr-15) via action of
Cdc25 and subsequent binding to cyclin B [60,61].
Damaged DNA during G2 phase triggers ATM and
Figure 9 Cluster analysis of differentially- expressed genes involved in cell cycle regulation. Heat-map of gene expression levels at 3 and
7 hpi in triplicate (A, B, C). Folds of change in gene expression represented as a gradient of green and red color for low- and high-expression
intensity, respectively. Each row represents one gene that met analysis cutoff of average fold change ≥1.8 in at least one of the two time points
and P-value ≤ 0.05 in both. Genes fell in three cell cycle pathways with some genes functioning in more than one pathway (A) cell cycle: G1/S
checkpoint regulation pathway (B) cell cycle: G2/M checkpoint regulation pathway (C) cell cycle regulation by BTG family proteins pathway.
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[62-64], which in turn activates two key kinases, Chk2
and Chk1[65,66]. The latter kinase inhibits Cdc25B and
Cdc25C which function as a phosphorylase that activate
Cdc2 before binding to cyclin B and entry into mitosis
[67]. Our results showed that ATR/ATM, and Chk1,
which activate sequentially in response to DNA abnorm-
a l i t i e s ,e x h i b i t e dn oo ro n l yas u b t l ec h a n g ei nt h e i r
expression in both time points, suggesting retention of
their Cdc25B/C inhibitory effect as in non-infected cells.
Three essential molecules needed for entry into mitosis
exhibited substantial downregulation; Cdc25B/C and
cyclin B exhibited -4.33, -1.91, -4.48 FC at 7 hpi and
-1.81, -2.27, -1.71 FC at 3 hpi respectively. The observed
regulation of these genes would intensify this checkpoint
signaling leading to a further delay in entry into mitosis
(Fig. 9C).
Discussion
Apoptosis is a natural controlled cell death mechanism
triggered by diverse stimuli to maintain tissue homeosta-
sis and eliminate abnormal or infected cells [68]. Because
apoptosis represents an important part of antiviral host
response, poxviruses developed numerous ways to target
it and disrupt its function [69]. Diverse anti-apoptotic
viral strategies are identified in different poxviruses, e.g.,
Molluscum contagiosum virus (MCV) inhibits caspase-8
by expressing MC159 gene, which encodes a protein that
binds procaspase-8 and Fas-associated death domain,
thereby inhibiting death receptor-induced apoptosis
mediated by Fas, TNF, or TRAIL receptors [70]. MC066
gene encodes a protein with glutathione peroxidase-like
function to convert oxygen-reactive species to neutral
molecules, hence preventing apoptosis triggered by
increased oxidative stress associated with infection [71].
Little is known about apoptosis in cells infected with
MPV, but related orthopoxviruses exhibit clear anti-
apoptotic functions. Cowpox virus for instance expresses
a protein that can block apoptosis in multiple ways. One
of the most potent anti-apoptotic proteins is the cytokine
response modifier A (CrmA) which inhibits caspase-8,
caspase-10, and blocks garnzyme B-mediated apoptosis
[72,73]. Similarly, Vaccinia viruses use SPI-2 family pro-
tein member of serine protease inhibitors (serpins)
encoded by B13R gene to block apoptosis induced by
death receptors [74]. The same virus inhibits apoptosis
induced by RNA-dependent protein kinase (PKR) using
specific PKR inhibitors encoded by E3L and K3L genes
[75], and apoptosis induced by loss of mitochondria
outer membrane potential by expression of F1L gene
[76].
The presence of many viral proteins that block apop-
tosis at multiple points suggests that apoptosis is detri-
mental to viral survival. However, the observed
downregulation of Bcl-2, PUMA, and PAK2 and upregu-
lation of NOXA and caspase-3 with the negligible
change in other apoptotic genes in our data is more
consistent with apoptosis induction. Although many
pathogens and viruses other than poxviruses are
reported to promote apoptosis [77], it is unlikely that
MPV will differ from other poxviruses in their common
anti-apoptotic trend, and the observed divergence
between the regulation of apoptosis-specific genes in
MPV-infected cells and overall anti-apoptotic outcome
seen in other poxvirus-infected cells suggests an anti-
apoptotic viral mechanism that functions downstream of
apoptosis induction in the host. MPV genes involved in
blocking apoptosis remain unknown, but our data sug-
gests the presence of an ortholog(s) of Vaccinia virus
(F1L) gene in MPV, which acts directly on the mito-
chondria in Bcl-2 like manner.
Double-stranded DNA mammalian viruses have large
genomes reaching 289 Kbp or few hundreds of micro-
meters in length as in the case of fowlpox virus [78].
Compacting the genome is an indispensible biological
task due to the rich negative charge and large size of
DNA molecules. In eukaryotes, this was solved by wrap-
ping DNA around a heterooctameric molecule com-
posed of four dimerized, positively charged core
histones to form nucleosomes. Further stability is
brought about by linker histones that bind DNA later-
ally. Nucleosomes, in a nucleofilaments form or in a
form of higher-order-structure assemblies, chromatin,
play an essential role in the regulation of gene expres-
sion and chromatin remodeling via acetylation and dea-
cetylation of the N-terminal histone tails protruding
from nucleosomes. Viruses exhibit similar architecture
in their DNA compaction. Staining vaccinia-infected
cells with osmium ammine-SO2 revealed areas with con-
centrated viral DNA in two predominant DNA config-
urations varying depending on the level of viral
synthetic activities. Encapsidated genomes exhibited a
nucleosome structure like those observed in resting
eukaryotes, which was in agreement with biochemical
data showing the supercoiled organization of nucleopro-
teins extracted from Vaccinia viruses [79]. On the other
hand, like active cellular chromatin, non-encapsidated
viral genomes exhibited extended DNA features [80].
Similar variation in DNA density was observed in
Herpes simplex viruses (HSV), another double stranded
DNA virus, with two well described configurations of
euchromatin or heterochromatin that correlated strongly
with lytic or latent HSV infection stages, respectively.
Generally, little is known about chromatin potential in
poxviruses as an antiviral mechanism. Our results
showed an interesting downregulation of five essential
histone expression regulation factors and five enzymes
regulating chromatin dynamics in MPV-infected cells. It
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which include chromatin-mediated silencing of the viral
genome and activation of DNA damage [81], or part of
the viral strategies to take over its host. However, our
observation predicts an important role for histone
expression, histone posttranslational modification, and
dynamic exchanges of chromatin in host-poxvirus inter-
actions. Recent work suggested a role for the viral A32L
gene of Vaccinia virus in DNA packaging based on
sequence similarities with the product of gene I of fila-
mentous single-stranded DNA bacteriophages and the
Iva2 gene of adenoviruses. Both of these genes are
ATPases involved in DNA packaging. Additional Vacci-
nia genes that map to I6 or I1 telomere-binding pro-
teins are believed to play roles in DNA packaging,
because mutants of VACV in either of these two genes
fail to exhibit normal DNA packaging at different mor-
phogenesis stages. The sharp upregulation we observed
in three out the four core histones, and the striking
similarities in DNA compaction architecture observed in
eukaryotes and some viruses, with absence of known
poxvirus proteins that exhibit histone-like properties
m a k e si tt e m p t i n gt oh y p o t h e s i z ear o l eo fh o s tc e l l
histones in viral DNA compaction and nucleosome
formation, especially that similar involvement was
described recently in simian virus 40 (SV40) DNA com-
paction [82]
Our analysis identified ephrin receptor pathway (ERP)
as a major influenced pathway in infected cells. This
might be due to either increased cell to cell communica-
tion by signaling through this receptor tyrosine kinases
(RTK) family in response to infection, or to the presence
of many pleiotropic genes that are found in ERP, and
simultaneously have essential roles in cytoskeleton reor-
ganization or actin polymerization. Intracellular viral
motility and morphogenesis of Vaccinia virus into a
cell-associated enveloped virion (CEV) and extracellular
enveloped virions (EEV) forms are shown to be driven
by interactions of host microtubules and Vaccinia A27L,
A17L and A14L genes. Furthermore, egress of Vaccinia
particles in EEV form and direct cell-to-cell virus disse-
mination is propelled by actin tail formation, which
involves the interactions of Vaccinia transport genes,
including A36R, F12L, and host proteins such as Src
family kinases (SFK), Nck, WIP, N-WASP, Arp 2/3 to
promote actin filaments nucleation. Actin polymeriza-
tion produces microvilli at cell surface that lift CEV and
project it on adjacent cells to finally deliver the virus
with minimal exposure to host immune system. Our
results confirm regulation of many principal signaling
components involved in actin cytoskeletal dynamics, and
introduce additional infection regulated genes with func-
tions related to microtubules signaling. This includes
intersectin 1 (SH3 domain protein) gene, which encodes
a cytoplasmic membrane-associated protein that indir-
ectly coordinates endocytic membrane traffic with the
actin assembly machinery, Rho-effector ROCK1 serve a
number of key cellular functions, such as morphological
differentiation and cell motility which are closely asso-
ciated with changes in cytoskeletal dynamics [83]. Addi-
tionally, RAS p21 protein activator (GTPase activating
protein) [84], v-Ki-ras2 Kirsten rat sarcoma viral onco-
gene homolog [85] and SOS2 [86] are crucial genes in
polymerization of actin filaments and cytoskeleton
reorganization.
Ion channels represent an intriguing and novel class of
genes that were impacted by MPV infection. We identi-
fied 10 genes encoding nine ion channels and a trans-
porter that underwent increasing suppression during
infection. Most of these channels localize to cell mem-
brane, and collectively contribute to transport of all
essential ions involved in maintenance of cell membrane
potential and osmolarity homeostasis. While mechan-
isms of transport modulation have been described pre-
viously, as in the indirect consequences of Ras, Rho, and
Rab small GTPases regulation [87], its effect on viral
infections and global cell biology remain unclear except
for a recent report describing the interaction of myxoma
poxvirus protein M11L with mitochondrial permeability
transition pore and its role in delaying apoptosis in host
cells [88]. The downregulation trend of channel expres-
sion identified here pose many intriguing questions,
especially in the light of evolving evidence in support of
ion channels role in virus release [89] and infected cells
rupture [90].
Progression of the cell cycle is tightly regulated pro-
cess with many redundant checkpoints that ensure
proper transition across cell cycle phases. Our results
showed significant modulation in the expression of
many genes that play essential roles in cell cycle regula-
tion, which led to the identification of ATM signaling,
G2/M DNA damage checkpoint, regulation by BTG
family protein, and G1/S checkpoint as major influenced
pathways during MPV infection. A core cell cycle regu-
lation gene, Cdc25 kinase, has three essential homologs
Cdc 25A/B/C that exhibited significant regulation upon
MPV infection. While Cdc25B/C showed downregula-
tion favoring cell arrest in G2 phase, Cdc2A exhibited
upregulation, favoring S phase progression. The impact
of this mode of cell cycle regulation on viral infection
remains unknown. However, cell arrest in G2 phase was
described in other viral infections including human
immunodeficiency virus (HIV) and was found to be
mainly mediated by viral protein R (Vpr) [91-93]. While
many of the G2/M DNA damage checkpoint pathway
genes are known to be modulated during HIV infection,
Vpr seems to induce cell arrest by molecular mechan-
isms other than the classic DNA check point [94].
Alkhalil et al. Virology Journal 2010, 7:173
http://www.virologyj.com/content/7/1/173
Page 16 of 19Recently, evidence supporting a role for PP2A in Vpr-
induced arrest has emerged, and was substantiated
further by other studies in support of PP2A being a
common target during infection with other viruses,
including simian virus 40 (SV40), polyoma virus, human
T lymphotrophic retrovirus and adenovirus [95]. Our
results showed significant downregulation in two PP2A
isoforms, regulatory subunit B’ gamma isoform
(PPP2R5C) and protein phosphatase 2, regulatory subu-
nit B’ epsilon isoform (PPP2R5E), suggesting that the
induction mechanisms of G2 arrest in MPV infection
might be similar to those observed in other viruses.
Because genetically diverse viruses seem to induce the
same G2 arrest response in different infected cells, it is
likely that this response has an important function and
m i g h tb ep a r to fa n t i v i r a lh o st defenses. While some of
the viral genes eliciting this response are being identified
as Vpr in HIV, and E4 of F4 and HTLV tax protein in
adenoviruses, the MPV gene inducing this response
remains unknown. Other important genes in cell cycle
regulation showing expression favoring progression of
cell cycle and arrest only in G2 phase include Rb, E2F,
cyclins, BTG1, and BRCA1.
In this study we combined microarray with data
mining and statistical analysis to identify important
interfaces of host-pathogen interaction. Our results
aligned nicely with previous reports carried out using
viruses from the same or different genus, and provided
new set of genes that play important roles in MPV
infection. Further work is warranted to validate and
examine the potential of these genes in antiviral
therapies.
Summary
Using microarrays, we studied MPV-induced changes in
gene expression of Macaca mulatta kidney epithelial
cells to identify major host-virus interaction interfaces.
Infection stimulated a marked modulation in some
2,702 host genes representing ≈ 5.7% of total interro-
gated host transcripts. The majority of genes (89.08%)
underwent 1.5-folds downregulation or more. While
downregulated genes exhibited a steady trend during the
study, upregulated genes showed more time-dependent
regulation intensity. Further data analysis showed that
regulated genes cluster into distinctive functional
classes, canonical pathways and networks that can be
linked to established viral biogenesis. Our results intro-
duce a set of host genes and novel pathways for further
evaluation as targets for potential use in developing new
antiviral therapies.
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